Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | BHMT | Q93088 | 1/20 | 0.34 |
| ▸ | GLRA3 | O75311 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22409043 | 0.77 | PIK3CD (0.48) | POLBDPP4PIK3CD | |
| SCHEMBL5656499 | 0.73 | ACE (0.44) | POLBMAPT | |
| SCHEMBL8189717 | 0.73 | ACE (0.44) | POLBMAPT | |
| SCHEMBL2058994 | 0.69 | PIK3CD (0.61) | POLBDPP4PIK3CD | |
| SCHEMBL2059377 | 0.68 | PIK3CD (0.50) | PIK3CD | |
| SCHEMBL7802821 | 0.68 | ALDH1A1 (0.41) | — | |
| SCHEMBL5371280 | 0.67 | KMT2A (0.39) | POLBPIK3CD | |
| SCHEMBL10563065 | 0.67 | — | — | |
| SCHEMBL7506208 | 0.66 | TSHR (0.35) | GLRA3 | |
| SCHEMBL15198795 | 0.65 | MMP1 (0.39) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | disclosed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |